Trellus Management Company’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-8,995
Closed -$216K 81
2017
Q1
$216K Buy
+8,995
New +$220K 0.33% 61
2016
Q4
Sell
-25,555
Closed -$769K 80
2016
Q3
$769K Sell
25,555
-8,144
-24% -$224K 1.11% 24
2016
Q2
$791K Sell
33,699
-8,401
-20% -$184K 1.29% 23
2016
Q1
$775K Buy
42,100
+2,645
+7% +$49.8K 1.35% 15
2015
Q4
$800K Hold
39,455
1.18% 25
2015
Q3
$862K Hold
39,455
1.26% 21
2015
Q2
$924K Hold
39,455
1.04% 24
2015
Q1
$1.03M Hold
39,455
1.22% 19
2014
Q4
$872K Hold
39,455
1.28% 22
2014
Q3
$717K Buy
39,455
+15,100
+62% +$302K 0.61% 47
2014
Q2
$522K Buy
24,355
+5,200
+27% +$111K 0.44% 62
2014
Q1
$433K Buy
19,155
+7,500
+64% +$183K 0.39% 66
2013
Q4
$284K Buy
+11,655
New +$275K 0.34% 70

Other funds holding SRDX

Trellus Management Company's SRDX Position: Q2 2017 in Review

Trellus Management Company sold out of Surmodics (SRDX) in Q2 2017, closing a stake of 8,995 shares — an estimated $216K sold.

Trellus Management Company first reported a position in SRDX in Q4 2013 and held it in 13 quarters. The position peaked at $1.03M in Q1 2015. 114 funds tracked by Wall St. Rank hold SRDX as of Q2 2017.

  • Trellus Management Company reported no remaining Surmodics position as of Q2 2017 after selling out during the quarter.
  • Trellus Management Company sold 8,995 Surmodics shares in Q2 2017, an estimated $216K.
  • Trellus Management Company first reported a position in Surmodics in Q4 2013 and held it in 13 quarters.
  • Trellus Management Company's Surmodics position peaked at $1.03M in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Surmodics as of Q2 2017.

Based on Trellus Management Company's 13F filing for Q2 2017, filed 25 Jul 2017.